Cartesian Therapeutics Inc (RNAC)
Investing Cash Flow
-$2.08M
TTM · Period ending: · USD
RNAC Investing Cash Flow
Latest reported-$2.08Mperiod ending
Latest reported-$2.08Mperiod ending
RNAC TTM Cash from Investing (-$4.68M → -$2.08M)
TTM investing cash flow
High-resolution chart · PNG
RNAC investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -2,083,000 | |
| -4,406,000 | |
| -5,454,000 | |
| -5,316,000 | |
| -10,223,000 | |
| -9,215,000 | |
| -8,742,000 | |
| -1,891,000 | |
| 4,308,000 | |
| 5,883,000 | |
| 34,609,000 | |
| 33,601,000 | |
| 3,664,000 | |
| 3,577,000 | |
| -15,002,000 | |
| -10,769,000 | |
| 17,366,000 | |
| 14,850,000 | |
| -17,140,000 | |
| -27,028,000 | |
| -25,512,000 | |
| -23,051,000 | |
| -741,000 | |
| -584,000 | |
| 11,214,000 | |
| 16,213,000 | |
| 229,000 | |
| -136,000 | |
| -5,632,000 | |
| 8,208,000 | |
| 25,272,000 | |
| 31,753,000 | |
| 23,366,000 | |
| 15,379,000 | |
| -2,098,000 | |
| -13,409,000 | |
| -31,248,000 | |
| -35,077,000 | |
| -22,100,000 | |
| -19,805,000 | |
| -812,000 | |
| -8,111,000 | |
| -4,679,000 |